Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Illumina Inc

ILMN
Current price
114.34 USD +4.57 USD (+4.16%)
Last closed 109.79 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 17 434 652 672 USD
Yield for 12 month -46.54 %
Week
Month
Year
ILMN
21.11.2021 - 28.11.2021

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California. Address: 5200 Illumina Way, San Diego, CA, United States, 92122

Analytics

WallStreet Target Price

131.5 USD

P/E ratio

Dividend Yield

2.17 %

Current Year

+4 584 000 000 USD

Last Year

+4 526 000 000 USD

Current Quarter

+1 119 000 000 USD

Last Quarter

+1 176 000 000 USD

Current Year

+2 972 000 000 USD

Last Year

+3 154 000 000 USD

Current Quarter

+684 000 000 USD

Last Quarter

+732 000 000 USD

Key Figures ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 317 000 000 USD
Operating Margin TTM 1.25 %
PE Ratio
Return On Assets TTM -0.65 %
PEG Ratio 4.1783
Return On Equity TTM -17.82 %
Wall Street Target Price 131.5 USD
Revenue TTM 4 464 999 936 USD
Book Value 37.33 USD
Revenue Per Share TTM 28.3 USD
Dividend Share
Quarterly Revenue Growth YOY 0.4 %
Dividend Yield 2.17 %
Gross Profit TTM 3 145 000 000 USD
Earnings Share -7.1 USD
Diluted Eps TTM -7.1 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -96.5 %
Profit Margin -25.2 %

Dividend Analytics ILMN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 2.17 %
Last Split Factor 2:1
Payout Ratio
Last Split Date 23.09.2008
Dividend Date

Stock Valuation ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 104.1667
Enterprise Value Revenue 4.2046
Price Sales TTM 3.9047
Enterprise Value EBITDA -30.2313
Price Book MRQ 2.956

Financials ILMN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ILMN

For 52 weeks

89 USD 238.55 USD
50 Day MA 116.52 USD
Shares Short Prior Month 5 152 250
200 Day MA 175.98 USD
Short Ratio 2.2
Shares Short 5 416 908
Short Percent 3.82 %